首页> Hematological oncology> How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?

How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?

导出原文传递

翻译打印收藏纠错

第一作者： Carmen,de Ramon Ortiz

第一单位： Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.

作者： Carmen,de Ramon Ortiz ^[1] ; Sisi,Wang ^[2] ; Anastasios,Stathis ^[3] ; Francesco,Bertoni ^[4] ; Thorsten,Zenz ^[5] ; Urban,Novak ^[6] ; Federico,Simonetta ^[7]

作者单位： Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland. ^[1] Translational Research Center for Oncohematology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland. ^[2] Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. ^[3] Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.;Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland. ^[4] Department of Medical Oncology and Hematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland. ^[5] Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland. ^[6] Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland.;Translational Research Center for Oncohematology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland. ^[7]

关键词 CAR T cells CD19 targeting agents DLBCL

医学主题词人类(Humans);T淋巴细胞(T-Lymphocytes);肿瘤复发, 局部(Neoplasm Recurrence, Local);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);抗原, CD19(Antigens, CD19)

DOI 10.1002/hon.3237

PMID 37937474

发布时间 2024-01-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交